- Home
- FMAO vs ABSI Comparison
FMAO vs ABSI Comparison
Compare FMAO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMAO
- ABSI
- Stock Information
- Founded
- FMAO 1897
- ABSI 2011
- Country
- FMAO United States
- ABSI United States
- Employees
- FMAO N/A
- ABSI N/A
- Industry
- FMAO Savings Institutions
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- FMAO Finance
- ABSI Health Care
- Exchange
- FMAO Nasdaq
- ABSI Nasdaq
- Market Cap
- FMAO 356.9M
- ABSI 338.0M
- IPO Year
- FMAO N/A
- ABSI 2021
- Fundamental
- Price
- FMAO $26.13
- ABSI $2.39
- Analyst Decision
- FMAO
- ABSI Strong Buy
- Analyst Count
- FMAO 0
- ABSI 5
- Target Price
- FMAO N/A
- ABSI $7.98
- AVG Volume (30 Days)
- FMAO 21.8K
- ABSI 4.4M
- Earning Date
- FMAO 10-29-2025
- ABSI 08-12-2025
- Dividend Yield
- FMAO 3.34%
- ABSI N/A
- EPS Growth
- FMAO 38.39
- ABSI N/A
- EPS
- FMAO 2.16
- ABSI N/A
- Revenue
- FMAO $108,632,000.00
- ABSI $4,138,000.00
- Revenue This Year
- FMAO $1.60
- ABSI $44.71
- Revenue Next Year
- FMAO $13.77
- ABSI $374.26
- P/E Ratio
- FMAO $12.26
- ABSI N/A
- Revenue Growth
- FMAO 13.86
- ABSI 27.32
- 52 Week Low
- FMAO $20.88
- ABSI $2.01
- 52 Week High
- FMAO $34.15
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- FMAO 58.09
- ABSI 33.33
- Support Level
- FMAO $24.60
- ABSI $2.50
- Resistance Level
- FMAO $27.01
- ABSI $2.73
- Average True Range (ATR)
- FMAO 0.81
- ABSI 0.18
- MACD
- FMAO 0.23
- ABSI -0.04
- Stochastic Oscillator
- FMAO 89.44
- ABSI 1.94
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.